Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia

被引：25
|
作者：
Carpenter, William T., Jr. [1 ]
Buchanan, Robert W. [1 ]
机构：
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
来源：
JAMA PSYCHIATRY | 2015年 / 72卷 / 08期
关键词：
FLUPHENAZINE;
D O I：
10.1001/jamapsychiatry.2015.0485
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [21] Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia
    Olivares, Jose M.
    Pinal, Beatriz
    Cinos, Carmen
    NEUROPSYCHIATRY, 2011, 1 (03) : 275 - 289
  • [22] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [23] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [24] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [25] Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
    Kudo, Shuhei
    Isioka, Masamichi
    Kubo, Kazutosi
    Kudo, Shuhei
    Sato, Yasusi
    Sugawara, Norio
    Yasui-Furukori, Norio
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 194 - 195
  • [26] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [27] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    John M. Kane
    Joseph P. McEvoy
    Christoph U. Correll
    Pierre-Michel Llorca
    CNS Drugs, 2021, 35 : 1189 - 1205
  • [28] Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
    Bhatta, Madhav P.
    Bista, Saroj
    El Khoury, Antoine C.
    Hutzell, Eric G.
    Tandon, Neeta
    Smith, Douglas
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 63 - 70
  • [29] RISK OF BREAKTHROUGH SYMPTOMS ON ANTIPSYCHOTIC MEDICATION WHEN REMITTED PATIENTS WITH SCHIZOPHRENIA ARE TREATED WITH LONG-ACTING INJECTABLE MEDICATIONS: PRELIMINARY RESULTS
    Zipursky, Robert
    Agid, Ofer
    Remington, Gary
    Spandier, Olivia
    Sung, Nicole
    Chen, Sheng
    Wang, Wei
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 559 - 560
  • [30] Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis
    Fitzgerald, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1999, 33 (05): : 660 - 666
12345